123.05
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$123.60
Offen:
$122.67
24-Stunden-Volumen:
728.75K
Relative Volume:
0.91
Marktkapitalisierung:
$8.80B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
11.46
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
+1.25%
1M Leistung:
-0.69%
6M Leistung:
-14.54%
1J Leistung:
-21.76%
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DVA
Davita Inc
|
123.05 | 8.73B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
473.28 | 108.07B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
196.66 | 17.58B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.70 | 13.88B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
227.57 | 14.27B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
114.28 | 11.55B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Why DaVita Inc. stock stays on buy listsQuarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
Using AI based signals to follow DaVita Inc.Short Setup & Real-Time Market Trend Scan - newser.com
How DaVita Inc. (TRL) stock expands through international markets2025 Support & Resistance & Fast Gaining Stock Reports - newser.com
Is DaVita Inc. (TRL) stock testing key supportFed Meeting & Advanced Technical Analysis Signals - newser.com
Can DaVita Inc. (TRL) stock retain market dominanceMarket Rally & Expert-Curated Trade Recommendations - newser.com
Has DaVita Inc. formed a bullish divergenceJuly 2025 Movers & Community Verified Swing Trade Signals - newser.com
Jim Cramer Discusses DaVita’s (DVA) Share Price Movement - MSN
Technical analysis overview for DaVita Inc. stockJuly 2025 Final Week & Safe Entry Trade Signal Reports - newser.com
ROCKWELL MEDICAL, INC. SEC 10-Q Report - TradingView
Is DaVita Inc. stock bottoming outAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
DaVita Inc.’s volatility index tracking explainedEntry Point & Low Risk Entry Point Tips - newser.com
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know - Yahoo Finance
Sentiment analysis tools applied to DaVita Inc.July 2025 Levels & Technical Buy Zone Confirmations - newser.com
DaVita Inside: Expansion of At-Home Dialysis & Sustained ESRD Patient Growth To Shape The Future in Kidney Care! - Smartkarma
DaVita Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Will DaVita Inc. rebound enough to break evenEarnings Recap Report & Low Risk Profit Maximizing Plans - newser.com
Is DaVita Inc. stock safe for conservative investorsEntry Point & Low Risk Entry Point Tips - newser.com
DaVita Stock: Analyst Estimates & Ratings - Barchart.com
Is DaVita Inc. (TRL) stock safe for risk averse investorsQuarterly Growth Report & Expert Curated Trade Setups - newser.com
Can DaVita Inc. stock maintain operating marginsPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - newser.com
Will DaVita Inc. stock deliver better than expected guidanceJuly 2025 Update & High Conviction Buy Zone Alerts - Fundação Cultural do Pará
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):